 "Sun Pharma")
Sun Pharma stock is yet to recover from Wednesday's fall on the bourses when it hit a six-month low after a foreign brokerage firm raised concerns around corporate governance practices at the drug major. The stock was further down 1.31 per cent from Wednesday's closing in morning trade.
The stock is currently trading at Rs 480 a piece on BSE. On November 28 Sun Pharma stock fell 3 per cent during the day but recovered partially to close at Rs 486.35 a piece on the BSE, down 1.47 per cent.
An email sent to Sun Pharma was not immediately answered.
